Blood Coagulation Disorders, InheritedChildren's health
What this study is
The objective of this study will be to assess the coagulation system in-vitro in a variety of bleeding and clotting disorders using the ROTEG analyzer and the thrombin generation assay.
Study details
- Official title
- Evaluation of Hemostasis in Bleeding and Thrombotic Disorders Using the Roteg Analyzer and the Thrombin Generation Assay
- Sponsor
- The University of Texas Health Science Center, Houston
- Conditions
- Blood Coagulation Disorders, Inherited · Thrombotic Disorder
- Enrolling
- 1,000 people
- Starts
- 2002-10
- Est. completion
- 2028-01
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 1 Day – 98 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- Patients with congenital or acquired bleeding or clotting disorders who have provided informed consent and/or assent
You can't join if
- Poor venous access
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
1
Study locations (2)
2 openThe Univerisity of Texas Health Science Center at Houston
Houston, Texas, United States
- Katherine Addy, RN, BSN, MPH · Contact713-500-8352Katherine.E.Addy@uth.tmc.edu
- Miguel Escobar, MD · Contact
RecruitingUT Physicians Women's Center-Texas Medical Center
Houston, Texas, United States
- Randa Jalloul, MD · Contact(832) 325-7131randa.j.jalloul@uth.tmc.edu
- Randa Jalloul, MD · Contact
Recruiting
Study team
Sponsor
The University of Texas Health Science Center, Houston
Study ID HSC-MS-02-174
Principal investigator
Miguel Escobar, M.D.
The University of Texas Health Science Center, Houston
Have questions? The contacts above can answer them before you apply.
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.